Technology
Health
Biotechnology

Proteon Therapeutics

$0.4121
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.001 (0.24%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell PRTO and other stocks, options, ETFs, and crypto commission-free!

About PRTO

Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. Read More The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.

Employees
17
Headquarters
Waltham, Massachusetts
Founded
2001
Market Cap
8.13M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
479.45K
High Today
$0.425
Low Today
$0.411
Open Price
$0.415
Volume
139.78K
52 Week High
$3.94
52 Week Low
$0.35

Collections

Technology
Health
Biotechnology
Therapy
Research And Development
Biopharmaceutical
Pharmaceutical
2014 IPO

PRTO Earnings

-$0.45
-$0.37
-$0.30
-$0.22
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.